Boston Scientific Acquires Rhythmia Medical for up to $265 Million
Norwich portfolio company Rhythmia Medical was acquired yesterday by Boston Scientific (NASDAQ: BSX). As with any acquisition of a portfolio company, it is a bittersweet moment. We invested in the founders, Leon Amariglio and Doron Harlev, six years ago and have been able to see them take an exciting idea and turn it into an industry-changing technology. It’s wonderful to see them realize a significant outcome for their passion, risk and hard work (the sweet part). Unfortunately, it also means our time working with the company and watching it grow has to come to an end (the bitter part). We wish the best for Boston Scientific as they build out their electrophysiology business.
You can read the press release at http://www.prnewswire.com/news-releases/boston-scientific-to-acquire-rhythmia-medical-inc-173172731.html